Industry News

Actavis and Warner Chilcott Receive Approval from Irish High Court For Pending Warner Chilcott Acquisition
Medicare agency won't pay for Eli Lilly imaging drug for Alzheimer's diagnoses
3 Dream Devices Take Top Honors in MedTech Design Contest
Medical device makers urge repeal of Obamacare tax
Medicare agency won't pay for Eli Lilly imaging drug for Alzheimer's diagnoses
Sun forays into gene therapy with JV
3 Dream Devices Take Top Honors in MedTech Design Contest
Medical device makers urge repeal of Obamacare tax
Global Vaccine Market Forecast to 2017
Data show Roche's new subcutaneous form of Herceptin is preferred by patients and could save resources in Europe's hospitals; Use of new Herceptin formulation reduced the time needed for pharmacists and doctors to treat patients; Subcutaneous
Merck to cut 8,500 more jobs
Construction work set to start on $93 million insulin factory
Merck to cut 8,500 more jobs
Construction work set to start on $93 million insulin factory
UBM Canon, the Global Authority on the MedTech Industry, Announces the Launch of MedTech World A new resource offering the best content the MedTech Industry has to offer, in one convenient place
Baxter makes layoffs at Medina facility
Rite Aid Named First National Retail Partner of Text4baby, the Largest Mobile Health Initiative for Mothers and Babies
Osmotica Announces the Commercial Launch of Its KHEDEZLA (desvenlafaxine) Extended-release Tablets, 50 mg and 100 mg
FDA Approves New Dosing Option for CSL Behring's Hizentra® New Hizentra Label Provides Primary Immunodeficiency Patients With the Flexibility to Self-Administer Their Treatment Less Frequently
Data show Roche's new subcutaneous form of Herceptin is preferred by patients and could save resources in Europe's hospitals; Use of new Herceptin formulation reduced the time needed for pharmacists and doctors to treat patients; Subcutaneous
FDA approves first pre-surgical breast cancer drug
Actavis and Warner Chilcott Receive Approval from Irish High Court For Pending Warner Chilcott Acquisition
Life in prison for NJ chemist who poisoned husband
Mylan Launches First Generic VFEND® for Oral Suspension - Company awarded 180 days marketing exclusivity -
Cimzia® (certolizumab pegol) approved by the U.S. FDA for treatment of adult patients with active psoriatic arthritis - Approval is supported by data from the RAPID™-PsA study and represents the third U.S. indication for Cimzia®